Validation of aorta–lesion–attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors-Reference-Cited by-同舟云学术

Validation of aorta–lesion–attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors

Published:2021-03-04 Issue:7 Volume:46 Page:3269-3279
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Grajo Joseph R.^ORCID,Batra Nikhil V.^ORCID,Bozorgmehri Shahab,Magnelli Laura L.,Pavlinec Jonathan,O’Malley Padraic,Su Li-Ming,Crispen Paul L.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-021-02971-7.pdf

Reference25 articles.

1. Flack CK, et al. (2019) Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma. Urol Oncol-Semin Ori 37:811.e17-811.e21. https://doi.org/10.1016/j.urolonc.2019.06.002.

2. Haifler M, Copel L, Sandbank J, Lang E, Raz O, Leibovici D, et al. (2012) Renal oncocytoma—are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis. Urol Oncol-Semin Ori 30:362-368. https://doi.org/10.1016/j.urolonc.2009.11.024.

3. Grajo JR, Terry RS, Ruoss J, et al. (2019) Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors. Urology 125:123-130. https://doi.org/10.1016/j.urology.2018.11.036.

4. Dhyani M, Grajo JR, Rodriguez D, et al. (2017) Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms. Abdom Radiol 42:1734-1743. https://doi.org/10.1007/s00261-017-1061-3.

5. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32-35.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging modalities for characterising T1 renal tumours: A systematic review and meta‐analysis of diagnostic accuracy;BJUI Compass;2024-06-21

2. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study;Academic Radiology;2023-11

3. “To Be or Not to Be Benign” at Partial Nephrectomy for Presumed RCC Renal Masses: Single-Center Experience with 195 Consecutive Patients;Diseases;2023-02-07

4. CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation;BMC Medical Imaging;2023-01-27

5. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma;Diagnostic and Interventional Radiology;2023-01-12